Journals / European Archives of Medical Research / 2019 / Cilt: 35 - Sayı: 4

Prediction of Single Dose Methotrexate Success in Ectopic Pregnancy Treatment

Pages
201–214
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Serum β-hCG levels on the day of methotrexate administration, β-hCGvalues at 4th day and at 7th day, and ectopic mass size were significantly higher in the failed group (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To investigate the efficacy of single-dose methotrexate treatment and the factors affecting its success in the treatment of ectopic pregnancy.Methods: Ectopic pregnancy cases treated with single dose methotrexate treatment between January 2013 and December 2017 were compared as successful andunsuccessful.
📊
Key Findings & Data:Demographic characteristics of patients, ectopic mass size, beta human chorionic gonodotropin (β-hCG) values at the beginning of treatment and at 4thand 7th days were evaluated.Results: A total of 462 patients, who underwent single dose methotrexate treatment as initial ectopic pregnancy treatment, were included in the study.
💡
Conclusion & Impact:Serum β-hCG levels on the day of methotrexate administration, β-hCGvalues at 4th day and at 7th day, and ectopic mass size were significantly higher in the failed group (p
🔬Design:Research Article
📍Scope:2013 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: To investigate the efficacy of single-dose methotrexate treatment and the factors affecting its success in the treatment of ectopic pregnancy.Methods: Ectopic pregnancy cases treated with single dose methotrexate treatment between January 2013 and December 2017 were compared as successful andunsuccessful. Demographic characteristics of patients, ectopic mass size, beta human chorionic gonodotropin (β-hCG) values at the beginning of treatment and at 4thand 7th days were evaluated.Results: A total of 462 patients, who underwent single dose methotrexate treatment as initial ectopic pregnancy treatment, were included in the study. Single dosemethotrexate treatment was successful in 350 patients (75.8%) and failed in 112 patients (24.2%). Serum β-hCG levels on the day of methotrexate administration, β-hCGvalues at 4th day and at 7th day, and ectopic mass size were significantly higher in the failed group (p

🔖

Cite This Article

MATHYK, B. A., ÇETİN, B. A. (2022). Prediction of Single Dose Methotrexate Success in Ectopic Pregnancy Treatment. European Archives of Medical Research, Cilt: 35 - Sayı: 4, 201–214. https://ajindex.com/articles/510450

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Lozeau AM, Potter B. Diagnosis and management of ectopic pregnancy. Am Fam Physician 2005;72:1707-14
  2. Chang J, Elem-Evans LD, Berg CJ, Herndon J, Flowers L, Seed KA, et al. Pregnancy-related mortality surveillance: United States, 1991-1999. MMWR 2003;52:1-8
  3. Atasü T, Sahmay S (Eds). Jinekoloji, 2. Baski, Nobel Yayınevi, İstanbul 2001:s.547-57
  4. Hajenius PJ, Mol F, Mol BW, Bossuyt PM, Ankum WM, Van der Veen F. Interventions for tubal ectopic pregnancy. Cochrane Database Syst Rev 2007;CD000324
  5. Stovall TG, Ling FW. Single dosemethotrexate: an expanded clinical trial. Am J Obstet Gynecol 1993;168:1759-65
  6. Kirk E, Condous G, Bourne T. The nonsurgical management of ectopic pregnancy. Ultrasound Obstet Gynecol 2006;27:91-100
  7. Fernandez H, Lelaidier C, Thouvenez V, Frydman R. The use of a pretherapeutic, predictive score to determine inclusion criteria for the nonsurgical treatment of ectopic pregnancy. Hum Reprod 1991;6:995-8
  8. Canis M, Savary D, Pouly JL, Wattiez A, Mage G. Ectopic pregnancy: criteria to decide betweenmedical and conservative surgical treatment? J Gynecol Obstet Biol Reprod 2003;32:S54-63
  9. Potter MB, Lepine LA, Jamieson DJ. Predictors of success with methotrexate treatment of tubal ectopic pregnancy at Grady Memorial Hospital. Am J Obstet Gynecol 2003;188:1192-4
  10. Nazac A, Gervaise A, Bouyer J, de Tayrac R, Capella-Allouc S, Fernandez H. Predictors of success in methotrexate treatment of women with unruptured tubal pregnancies. Ultrasound Obstet Gynecol 2003;21:181-5
  11. Dilbaz S, Caliskan E, Dilbaz B, Degirmenci O, Haberal A. Predictors of methotrexate treatment failure in ectopic pregnancy. J Reprod Med 2006;51:87-93
  12. Mol F, Mol BW, Ankum WM, van der Veen F, Hajenius PJ. Current evidence on surgery, systemic methotrexate and expectant management in the treatment of tubal ectopic pregnancy: a systematic review and meta-analysis. Hum Reprod Update 2008;14:309-19
  13. Merisio C, Anfuso S, Berretta R, Gualdi M, Pultrone D, et al. Single –dose methotrexate for Ectopic pregnancy treatment: preliminary data Acta Bio Med 2005;76:33-6
  14. Zargar M, Razi T, Barati M. Comparison of single and multidose of methotrexate in medical treatment of ectopic pregnancy. Pak J Med Sci 2008;24:586-9
  15. Gibbs R, Karlan B, Haney A. Danforth’s Obstetrics and Gynecology. Baltimore: Lippincott Williams and Wilkins; 2010
  16. The Management of tubal pregnancy. Royal college of obstetricians and gynaecologists guidelines 2004;21:1-10. 1